Trials / Completed
CompletedNCT04397991
Inhaled Furosemide for Transient Tachypnea of Newborn
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Makassed General Hospital · Academic / Other
- Sex
- All
- Age
- 1 Day – 1 Day
- Healthy volunteers
- Not accepted
Summary
This is a randomized double blind clinical trial in which newborns with suspected Transient tachypnea of the newborn (TTN) will receive either furosemide or normal saline by nebulizer every 6 hours for 24 hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Furosemide | Patients will receive nebulised furosemide solution 1 mg/kg |
| OTHER | Placebo | Patients will receive nebulised 0.9% saline |
Timeline
- Start date
- 2020-01-02
- Primary completion
- 2021-08-01
- Completion
- 2021-08-01
- First posted
- 2020-05-21
- Last updated
- 2022-08-30
Locations
1 site across 1 country: Lebanon
Source: ClinicalTrials.gov record NCT04397991. Inclusion in this directory is not an endorsement.